Toshiyuki Hirakata

  • Citations Per Year
Learn More
OBJECTIVES To evaluate the efficacy and safety of 2 years of treatment with intramuscular interferon beta-1a (IM IFN beta-1a) in Japanese patients with relapsing-remitting multiple sclerosis, with an exploratory analysis of the impact of initial dose titration on tolerability. METHODS Japanese patients with relapsing-remitting multiple sclerosis were(More)
  • 1